{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T00:48:54Z","timestamp":1793753334389,"version":"4.6.1"},"reference-count":92,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T00:00:00Z","timestamp":1664409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research, New Delhi, India","doi-asserted-by":"publisher","award":["VIR\/32\/2019\/ECD-I"],"award-info":[{"award-number":["VIR\/32\/2019\/ECD-I"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Viruses"],"abstract":"<jats:p>The rising incidence of dengue virus (DENV) infections in the tropical and sub-tropical regions of the world emphasizes the need to identify effective therapeutic drugs against the disease. Repurposing of drugs has emerged as a novel concept to combat pathogens. In this study, we employed a transcriptomics-based bioinformatics approach for drug identification against DENV. Gene expression omnibus datasets from patients with different grades of dengue disease severity and healthy controls were used to identify differentially expressed genes in dengue cases, which were then applied to the query tool of Connectivity Map to identify the inverse gene\u2013disease\u2013drug relationship. A total of sixteen identified drugs were investigated for their prophylactic, virucidal, and therapeutic effects against DENV. Focus-forming unit assay and quantitative RT-PCR were used to evaluate the antiviral activity. Results revealed that five compounds, viz., resveratrol, doxorubicin, lomibuvir, elvitegravir, and enalaprilat, have significant anti-DENV activity. Further, molecular docking studies showed that these drugs can interact with a variety of protein targets of DENV, including the glycoprotein, the NS5 RdRp, NS2B-NS3 protease, and NS5 methyltransferase The in vitro and in silico results, therefore, reveal that these drugs have the ability to decrease DENV-2 production, suggesting that these drugs or their derivatives could be attempted as therapeutic agents against DENV infections.<\/jats:p>","DOI":"10.3390\/v14102150","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T01:43:01Z","timestamp":1664502181000},"page":"2150","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["A Transcriptomics-Based Bioinformatics Approach for Identification and In Vitro Screening of FDA-Approved Drugs for Repurposing against Dengue Virus-2"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7557-9289","authenticated-orcid":false,"given":"Madhura","family":"Punekar","sequence":"first","affiliation":[{"name":"Dengue & Chikungunya Group, ICMR-National Institute of Virology, 20-A, Dr Ambedkar Road, Pune 411001, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0380-7494","authenticated-orcid":false,"given":"Bhagyashri","family":"Kasabe","sequence":"additional","affiliation":[{"name":"Bioinformatics Group, ICMR-National Institute of Virology, 20-A, Dr Ambedkar Road, Pune 411001, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Patil","sequence":"additional","affiliation":[{"name":"Dengue & Chikungunya Group, ICMR-National Institute of Virology, 20-A, Dr Ambedkar Road, Pune 411001, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahadeo B.","family":"Kakade","sequence":"additional","affiliation":[{"name":"Dengue & Chikungunya Group, ICMR-National Institute of Virology, 20-A, Dr Ambedkar Road, Pune 411001, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2688-3684","authenticated-orcid":false,"given":"Deepti","family":"Parashar","sequence":"additional","affiliation":[{"name":"Dengue & Chikungunya Group, ICMR-National Institute of Virology, 20-A, Dr Ambedkar Road, Pune 411001, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1401-8589","authenticated-orcid":false,"given":"Kalichamy","family":"Alagarasu","sequence":"additional","affiliation":[{"name":"Dengue & Chikungunya Group, ICMR-National Institute of Virology, 20-A, Dr Ambedkar Road, Pune 411001, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cherian","sequence":"additional","affiliation":[{"name":"Bioinformatics Group, ICMR-National Institute of Virology, 20-A, Dr Ambedkar Road, Pune 411001, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1128\/CMR.11.3.480","article-title":"Dengue and Dengue Hemorrhagic Fever","volume":"11","author":"Gubler","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_2","unstructured":"(2022, January 17). Dengue and Severe Dengue. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dengue-and-severe-dengue."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/B978-0-12-819400-3.00016-8","article-title":"Dengue Virus","volume":"1","author":"Murugesan","year":"2020","journal-title":"Emerg. Reemerging Viral Pathog."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00408-017-0021-6","article-title":"Dengue Hemorrhagic Fever: A State-of-the-Art Review Focused in Pulmonary Involvement","volume":"195","author":"Paim","year":"2017","journal-title":"Lung"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"997","DOI":"10.2741\/4630","article-title":"Drug Repurposing Approaches to Fight Dengue Virus Infection and Related Diseases","volume":"23","author":"Botta","year":"2018","journal-title":"Front. Biosci. Landmark Ed."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Rudrapal, M., Khairnar, S.J., and Jadhav, A.G. (2020). Drug Repurposing (DR): An Emerging Approach in Drug Discovery, IntechOpen.","DOI":"10.5772\/intechopen.93193"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"588654","DOI":"10.3389\/fphar.2020.588654","article-title":"Challenges for Drug Repurposing in the COVID-19 Pandemic Era","volume":"11","author":"Sultana","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03256811","article-title":"Repurposing Strategies for Therapeutics","volume":"24","author":"Sleigh","year":"2010","journal-title":"Pharm. Med."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Low, Z.Y., Farouk, I.A., and Lal, S.K. (2020). Drug Repositioning: New Approaches and Future Prospects for Life-Debilitating Diseases and the COVID-19 Pandemic Outbreak. Viruses, 12.","DOI":"10.3390\/v12091058"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Nascimento, E.J.M., Braga-Neto, U., Calzavara-Silva, C.E., Gomes, A.L.V., Abath, F.G.C., Brito, C.A.A., Cordeiro, M.T., Silva, A.M., Magalh\u00e3es, C., and Andrade, R. (2009). Gene Expression Profiling during Early Acute Febrile Stage of Dengue Infection Can Predict the Disease Outcome. PLoS ONE, 4.","DOI":"10.1371\/journal.pone.0007892"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Soares-Schanoski, A., Baptista Cruz, N., de Castro-Jorge, L.A., de Carvalho, R.V.H., Santos, C.A.D., da R\u00f3s, N., Oliveira, \u00da., Costa, D.D., Santos, C.L.S.D., and Cunha, M.D.P. (2019). Systems Analysis of Subjects Acutely Infected with the Chikungunya Virus. PLoS Pathog., 15.","DOI":"10.1371\/journal.ppat.1007880"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"11259","DOI":"10.1128\/JVI.01424-16","article-title":"Characterization of Human CD8 T Cell Responses in Dengue Virus-Infected Patients from India","volume":"90","author":"Chandele","year":"2016","journal-title":"J. Virol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","article-title":"The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease","volume":"313","author":"Lamb","year":"2006","journal-title":"Science"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nrc2044","article-title":"The Connectivity Map: A New Tool for Biomedical Research","volume":"7","author":"Lamb","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1158\/0008-5472.CAN-05-2825","article-title":"Antiangiogenic Potential of the Mammalian Target of Rapamycin Inhibitor Temsirolimus","volume":"66","author":"Bufalo","year":"2006","journal-title":"Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1093\/annonc\/mdn066","article-title":"Temsirolimus Safety Profile and Management of Toxic Effects in Patients with Advanced Renal Cell Carcinoma and Poor Prognostic Features","volume":"19","author":"Bellmunt","year":"2008","journal-title":"Ann. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1038\/s41467-021-22166-4","article-title":"SARS-CoV-2 Infection Rewires Host Cell Metabolism and Is Potentially Susceptible to MTORC1 Inhibition","volume":"12","author":"Mullen","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.bbrc.2018.04.187","article-title":"A New Strategy to Identify Hepatitis B Virus Entry Inhibitors by AlphaScreen Technology Targeting the Envelope-Receptor Interaction","volume":"501","author":"Saso","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.2042-7158.2012.01567.x","article-title":"Doxorubicin: An Update on Anticancer Molecular Action, Toxicity and Novel Drug Delivery Systems","volume":"65","author":"Tacar","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1128\/AAC.00939-08","article-title":"Debio 025, a Cyclophilin Binding Molecule, Is Highly Efficient in Clearing Hepatitis C Virus (HCV) Replicon-Containing Cells when Used Alone or in Combination with Specifically Targeted Antiviral Therapy for HCV (STAT-C) Inhibitors","volume":"53","author":"Coelmont","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.bbrc.2006.12.063","article-title":"Anti-Enterovirus Activity and Structure-Activity Relationship of a Series of 2,6-Dihalophenyl-Substituted 1H,3H-Thiazolo[3,4-a]Benzimidazoles","volume":"353","author":"Heggermont","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1097\/01.aids.0000247111.58961.60","article-title":"Elimination of HIV-1 Infection by Treatment with a Doxorubicin-Conjugated Anti-Envelope Antibody","volume":"20","author":"Johansson","year":"2006","journal-title":"AIDS"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"585408","DOI":"10.3389\/fphar.2020.585408","article-title":"Vulnerabilities of the SARS-CoV-2 Virus to Proteotoxicity\u2014Opportunity for Repurposed Chemotherapy of COVID-19 Infection","volume":"11","author":"Abbas","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1128\/AAC.00686-10","article-title":"A Derivate of the Antibiotic Doxorubicin Is a Selective Inhibitor of Dengue and Yellow Fever Virus Replication In Vitro","volume":"54","author":"Kaptein","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1056\/NEJM200012143432402","article-title":"Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia","volume":"343","author":"Rai","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/7445","article-title":"Fludarabine-Induced Immunosuppression Is Associated with Inhibition of STAT1 Signaling","volume":"5","author":"Frank","year":"1999","journal-title":"Nat. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1073\/pnas.0813280106","article-title":"Long-Term Efficacy and Safety of All-Trans Retinoic Acid\/Arsenic Trioxide-Based Therapy in Newly Diagnosed Acute Promyelocytic Leukemia","volume":"106","author":"Hu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.clpt.2004.01.001","article-title":"Effect of Cytochrome P450 3A4 Inhibition on the Pharmacokinetics of Docetaxel","volume":"75","author":"Engels","year":"2004","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/sj.bjc.6602698","article-title":"Potential for Improvement of Docetaxel-Based Chemotherapy: A Pharmacological Review","volume":"93","author":"Engels","year":"2005","journal-title":"Br. J. Cancer"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10059-011-0066-y","article-title":"Association between Epstein-Barr Virus Infection and Chemoresistance to Docetaxel in Gastric Carcinoma","volume":"32","author":"Shin","year":"2011","journal-title":"Mol. Cells"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1349-7006.2003.tb01358.x","article-title":"Evodiamine, a Constituent of Evodiae Fructus, Induces Anti-Proliferating Effects in Tumor Cells","volume":"94","author":"Fei","year":"2003","journal-title":"Cancer Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.3390\/molecules14051852","article-title":"Evodiamine: A Novel Anti-Cancer Alkaloid from Evodia Rutaecarpa","volume":"14","author":"Jiang","year":"2009","journal-title":"Molecules"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF02968573","article-title":"Anti-Inflammatory Principles from the Fruits of Evodia Rutaecarpa and Their Cellular Action Mechanisms","volume":"29","author":"Choi","year":"2006","journal-title":"Arch. Pharm. Res."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Dai, J.-P., Li, W.-Z., Zhao, X.-F., Wang, G.-F., Yang, J.-C., Zhang, L., Chen, X.-X., Xu, Y.-X., and Li, K.-S. (2012). A Drug Screening Method Based on the Autophagy Pathway and Studies of the Mechanism of Evodiamine against Influenza A Virus. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0042706"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e6632623","DOI":"10.1155\/2021\/6632623","article-title":"Alkaloids as Potential Phytochemicals against SARS-CoV-2: Approaches to the Associated Pivotal Mechanisms","volume":"2021","author":"Majnooni","year":"2021","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Vidoni, C., Fuzimoto, A., Ferraresi, A., and Isidoro, C. (2021). Targeting Autophagy with Natural Products to Prevent SARS-CoV-2 Infection. J. Tradit. Complement. Med.","DOI":"10.1016\/j.jtcme.2021.10.003"},{"key":"ref_37","first-page":"3247","article-title":"Evodiamine Alleviates Severe Pneumonia Induced by Methicillin-Susceptible Staphylococcus Aureus Following Cytomegalovirus Reactivation through Suppressing NF-\u039aB and MAPKs","volume":"42","author":"Chen","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e24746","DOI":"10.4161\/cib.24746","article-title":"Staurosporine","volume":"6","author":"Cho","year":"2013","journal-title":"Commun. Integr. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40001-019-0365-x","article-title":"Staurosporine Induces Apoptosis in Pancreatic Carcinoma Cells PaTu 8988t and Panc-1 via the Intrinsic Signaling Pathway","volume":"24","author":"Malsy","year":"2019","journal-title":"Eur. J. Med. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"535","DOI":"10.7164\/antibiotics.48.535","article-title":"Staurosporine, a Potentially Important Gift from a Microorganism","volume":"48","author":"Omura","year":"1995","journal-title":"J. Antibiot."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2010.02.054","article-title":"Resveratrol, Obesity and Diabetes","volume":"635","author":"Szkudelska","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2174\/187152807781696464","article-title":"Anti-Inflammatory Responses of Resveratrol","volume":"6","author":"Das","year":"2022","journal-title":"Inflamm. Allergy Drug Targets Discontin."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10753-006-9012-0","article-title":"Effects of Resveratrol in Inflammatory Arthritis","volume":"30","author":"Elmali","year":"2007","journal-title":"Inflammation"},{"key":"ref_44","first-page":"1","article-title":"The Therapeutic Potential of Resveratrol: A Review of Clinical Trials","volume":"1","author":"Berman","year":"2017","journal-title":"Npj Precis. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.brainresrev.2006.04.004","article-title":"Resveratrol\u2014A Boon for Treating Alzheimer\u2019s Disease?","volume":"52","author":"Anekonda","year":"2006","journal-title":"Brain Res. Rev."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0308-8146(03)00157-2","article-title":"Resveratrol and Its Antioxidant and Antimicrobial Effectiveness","volume":"83","author":"Filip","year":"2003","journal-title":"Food Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1042\/BST0380050","article-title":"Antiviral Activity of Resveratrol","volume":"38","author":"Campagna","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1527-3466.2004.tb00139.x","article-title":"Cardiovascular Protective Effects of Resveratrol","volume":"22","author":"Bradamante","year":"2004","journal-title":"Cardiovasc. Drug Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1210\/jc.2015-2616","article-title":"Effectiveness of Metyrapone in Treating Cushing\u2019s Syndrome: A Retrospective Multicenter Study in 195 Patients","volume":"100","author":"Daniel","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1001\/archpsyc.61.12.1235","article-title":"Metyrapone as Additive Treatment in Major Depression: A Double-Blind and Placebo-Controlled Trial","volume":"61","author":"Jahn","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective Inhibition of BET Bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"10280","DOI":"10.1038\/s41598-019-46516-x","article-title":"Bromodomain Inhibitor JQ1 Reversibly Blocks IFN-\u03b3 Production","volume":"9","author":"Gibbons","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET Bromodomain Inhibition as a Therapeutic Strategy to Target C-Myc","volume":"146","author":"Delmore","year":"2011","journal-title":"Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1073\/pnas.1422165112","article-title":"An In-Tumor Genetic Screen Reveals That the BET Bromodomain Protein, BRD4, Is a Potential Therapeutic Target in Ovarian Carcinoma","volume":"112","author":"Baratta","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2020.09.003","article-title":"BRD4 Inhibition by JQ1 Prevents High-Fat Diet-Induced Diabetic Cardiomyopathy by Activating PINK1\/Parkin-Mediated Mitophagy In Vivo","volume":"149","author":"Mu","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/CIRCRESAHA.119.315125","article-title":"Dynamic Chromatin Targeting of BRD4 Stimulates Cardiac Fibroblast Activation","volume":"125","author":"Stratton","year":"2019","journal-title":"Circ. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1177\/0022034514534261","article-title":"BET Inhibitor JQ1 Blocks Inflammation and Bone Destruction","volume":"93","author":"Meng","year":"2014","journal-title":"J. Dent. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2119\/2006-00005.Dinarello","article-title":"The Histone Deacetylase Inhibitor ITF2357 Reduces Production of Pro-Inflammatory Cytokines In Vitro and Systemic Inflammation In Vivo","volume":"11","author":"Leoni","year":"2005","journal-title":"Mol. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-017-0174-5","article-title":"Givinostat Reduces Adverse Cardiac Remodeling through Regulating Fibroblasts Activation","volume":"9","author":"Milan","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s13148-010-0006-2","article-title":"Histone Deacetylase Inhibitors: Clinical Implications for Hematological Malignancies","volume":"1","author":"Tambaro","year":"2010","journal-title":"Clin. Epigenet."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Jaskulska, A., Janecka, A.E., and Gach-Janczak, K. (2020). Thapsigargin\u2014From Traditional Medicine to Anticancer Drug. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22010004"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"19656","DOI":"10.1074\/jbc.M117.796920","article-title":"Inhibition of the Sarco\/Endoplasmic Reticulum (ER) Ca2+-ATPase by Thapsigargin Analogs Induces Cell Death via ER Ca2+ Depletion and the Unfolded Protein Response","volume":"292","author":"Sehgal","year":"2017","journal-title":"J. Biol. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Al-Beltagi, S., Preda, C.A., Goulding, L.V., James, J., Pu, J., Skinner, P., Jiang, Z., Wang, B.L., Yang, J., and Banyard, A.C. (2021). Thapsigargin Is a Broad-Spectrum Inhibitor of Major Human Respiratory Viruses: Coronavirus, Respiratory Syncytial Virus and Influenza A Virus. Viruses, 13.","DOI":"10.3390\/v13020234"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Goulding, L.V., Yang, J., Jiang, Z., Zhang, H., Lea, D., Emes, R.D., Dottorini, T., Pu, J., Liu, J., and Chang, K.-C. (2020). Thapsigargin at Non-Cytotoxic Levels Induces a Potent Host Antiviral Response That Blocks Influenza A Virus Replication. Viruses, 12.","DOI":"10.3390\/v12101093"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s12245-016-0125-4","article-title":"Intravenous Enalaprilat for Treatment of Acute Hypertensive Heart Failure in the Emergency Department","volume":"9","author":"Ayaz","year":"2016","journal-title":"Int. J. Emerg. Med."},{"key":"ref_66","first-page":"81","article-title":"Critical Appraisal of Elvitegravir in the Treatment of HIV-1\/AIDS","volume":"6","author":"Pandey","year":"2014","journal-title":"HIVAIDS"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1345\/aph.1M309","article-title":"Integrase Inhibitors: A Novel Class of Antiretroviral Agents","volume":"44","author":"Schafer","year":"2010","journal-title":"Ann. Pharmacother."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1021\/acsmedchemlett.6b00479","article-title":"Discovery of Novel Allosteric HCV NS5B Inhibitors. 2. Lactam-Containing Thiophene Carboxylates","volume":"8","author":"Li","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Abdurakhmanov, E., \u00d8ie Solbak, S., and Danielson, U.H. (2017). Biophysical Mode-of-Action and Selectivity Analysis of Allosteric Inhibitors of Hepatitis C Virus (HCV) Polymerase. Viruses, 9.","DOI":"10.3390\/v9060151"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"104490","DOI":"10.1016\/j.bioorg.2020.104490","article-title":"Computational Drug Discovery and Repurposing for the Treatment of COVID-19: A Systematic Review","volume":"106","author":"Mohamed","year":"2021","journal-title":"Bioorg. Chem."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Parashar, D., Paingankar, M.S., Kumar, S., Gokhale, M.D., Sudeep, A.B., Shinde, S.B., and Arankalle, V.A. (2013). Administration of E2 and NS1 SiRNAs Inhibit Chikungunya Virus Replication in Vitro and Protects Mice Infected with the Virus. PLoS Negl. Trop. Dis., 7.","DOI":"10.1371\/journal.pntd.0002405"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12985-021-01517-z","article-title":"In Vitro and In Vivo Studies Reveal \u03b1-Mangostin, a Xanthonoid from Garcinia Mangostana, as a Promising Natural Antiviral Compound against Chikungunya Virus","volume":"18","author":"Patil","year":"2021","journal-title":"Virol. J."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Panda, K., Alagarasu, K., Patil, P., Agrawal, M., More, A., Kumar, N.V., Mainkar, P.S., Parashar, D., and Cherian, S. (2021). In Vitro Antiviral Activity of \u03b1-Mangostin against Dengue Virus Serotype-2 (DENV-2). Molecules, 26.","DOI":"10.3390\/molecules26103016"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","article-title":"PubChem Substance and Compound Databases","volume":"44","author":"Kim","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: A New Approach for Rapid, Accurate Docking and Scoring. 2. Enrichment Factors in Database Screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1073\/pnas.0832193100","article-title":"A Ligand-Binding Pocket in the Dengue Virus Envelope Glycoprotein","volume":"100","author":"Modis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1021\/cb400612h","article-title":"Allosteric Inhibition of the NS2B-NS3 Protease from Dengue Virus","volume":"8","author":"Yildiz","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e01294-19","DOI":"10.1128\/JVI.01294-19","article-title":"NS5 from Dengue Virus Serotype 2 Can Adopt a Conformation Analogous to That of Its Zika Virus and Japanese Encephalitis Virus Homologues","volume":"94","author":"Soh","year":"2019","journal-title":"J. Virol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.antiviral.2013.08.013","article-title":"Antibody-Dependent Enhancement of Dengue Virus Infection Is Inhibited by SA-17, a Doxorubicin Derivative","volume":"100","author":"Jarupathirun","year":"2013","journal-title":"Antiviral Res."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.3390\/v2122649","article-title":"The Complexity of Antibody-Dependent Enhancement of Dengue Virus Infection","volume":"2","author":"Guzman","year":"2010","journal-title":"Viruses"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Fried, J.R., Gibbons, R.V., Kalayanarooj, S., Thomas, S.J., Srikiatkhachorn, A., Yoon, I.-K., Jarman, R.G., Green, S., Rothman, A.L., and Cummings, D.A.T. (2010). Serotype-Specific Differences in the Risk of Dengue Hemorrhagic Fever: An Analysis of Data Collected in Bangkok, Thailand from 1994 to 2006. PLoS Negl. Trop. Dis., 4.","DOI":"10.1371\/journal.pntd.0000617"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.virusres.2018.07.018","article-title":"Drug Repurposing of Quinine as Antiviral against Dengue Virus Infection","volume":"255","author":"Malakar","year":"2018","journal-title":"Virus Res."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Paemanee, A., Hitakarun, A., Roytrakul, S., and Smith, D.R. (2018). Screening of Melatonin, \u03b1-Tocopherol, Folic Acid, Acetyl-l-Carnitine and Resveratrol for Anti-Dengue 2 Virus Activity. BMC Res. Notes, 11.","DOI":"10.1186\/s13104-018-3417-3"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.antiviral.2016.04.014","article-title":"Novel Antiviral Activity of Bromocriptine against Dengue Virus Replication","volume":"131","author":"Kato","year":"2016","journal-title":"Antiviral Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"606743","DOI":"10.3389\/fcimb.2020.606743","article-title":"Repurposing the Antiemetic Metoclopramide as an Antiviral against Dengue Virus Infection in Neuronal Cells","volume":"10","author":"Shen","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"42998","DOI":"10.1038\/srep42998","article-title":"Resveratrol Treatment Reveals a Novel Role for HMGB1 in Regulation of the Type 1 Interferon Response in Dengue Virus Infection","volume":"7","author":"Zainal","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000265166","article-title":"Doxorubicin Cardiomyopathy","volume":"115","author":"Chatterjee","year":"2010","journal-title":"Cardiology"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.drudis.2020.08.005","article-title":"Pharmacology of Enalapril in Children: A Review","volume":"25","author":"Smeets","year":"2020","journal-title":"Drug Discov. Today"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1007\/s00705-015-2581-1","article-title":"Losartan and Enalapril Decrease Viral Absorption and Interleukin 1 Beta Production by Macrophages in an Experimental Dengue Virus Infection","volume":"160","author":"Valero","year":"2015","journal-title":"Arch. Virol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"104637","DOI":"10.1016\/j.antiviral.2019.104637","article-title":"Antiviral Activity of the FDA-Approved Drug Candesartan Cilexetil against Zika Virus Infection","volume":"172","author":"Loe","year":"2019","journal-title":"Antiviral Res."}],"container-title":["Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/10\/2150\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:42:03Z","timestamp":1760143323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4915\/14\/10\/2150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,29]]},"references-count":92,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["v14102150"],"URL":"https:\/\/doi.org\/10.3390\/v14102150","relation":{},"ISSN":["1999-4915"],"issn-type":[{"value":"1999-4915","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,29]]}}}